Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-18

Clinical Trial Update: Dysphonia Pain Perception Following Botulinum Toxin Injections [NA]

View source ↗

Summary

A completed clinical trial evaluated pain perception following botulinum toxin injections in individuals with spasmodic dysphonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: University of British Columbia | Conditions: Spasmodic Dysphonia | NA | Status: COMPLETED